StocksMedium•3 November 2026•
1 min read
Mirum Pharmaceuticals Misses Q3 EPS Estimates and Issues Financial Guidance
Key Facts
1Mirum Pharmaceuticals reported a Q3 EPS miss of 38 cents against analyst estimates.
2The company provided forward-looking financial guidance alongside its quarterly results.
Mirum Pharmaceuticals reported a Q3 EPS miss of 38 cents against analyst estimates. StreetInsider reported that the company provided forward-looking financial guidance alongside its quarterly results.
MIRM closed at $85.74 on November 2, 2026, with the stock reaching a day high of $86.52 and a day low of $83.69 during that session.